ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
2
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,204
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Levels of EGFR T790M in plasma DNA as a predictive biomarker for response to AZD9291, a mutant-selective EGFR kinase inhibitor
Author(s):
K. Thress
,
J Yang
,
M. Ahn
,
D. Kim
,
S Kim
,
Y Ohe
,
D Planchard
,
R Brant
,
H Carr
,
S Dearden
,
S. Jenkins
,
M Cantarini
,
S. Ghiorghiu
Publication date:
2014
Journal:
Ann Oncol
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Oncology
Data availability:
ScienceOpen disciplines:
Oncology & Radiotherapy
,
Medicine
Comments
Comment on this article
Sign in to comment
Similar content
2,204
Preclinical evidence and clinical cases of AZD9291 activity in EGFR-mutant non-small cell lung cancer (NSCLC) brain metastases (BM)
Authors:
D KIM
,
J. Yang
,
D. CROSS
…
Self-optimisation of the final stage in the synthesis of EGFR kinase inhibitor AZD9291 using an automated flow reactor
Authors:
Richard Bourne
,
Robert L. Woodward
,
A Blacker
…
Effect of itraconazole or rifampicin on the pharmacokinetics (PK) of osimertinib (AZD9291).
Authors:
Karthick Vishwanathan
,
James Yang
,
Jong-Seok Lee
…
See all similar
Cited by
2
Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer
Authors:
Nicola Normanno
,
Marc G. Denis
,
Kenneth S Thress
…
Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experience
Authors:
Ivana Sullivan
,
David Planchard
See all cited by